Sands Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sands Capital Management, LLC

$31.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $410 Million - $521 Million	-856,472 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $9.29 Million - $11.2 Million	17,057 Added 2.03%	856,472 $479 Million
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $342,857 - $447,524	695 Added 0.08%	839,415 $524 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $4.7 Million - $6.92 Million	-13,991 Reduced 1.64%	838,720 $410 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $10.1 Million - $13.8 Million	-36,777 Reduced 4.13%	852,711 $320 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $22.3 Million - $26 Million	-81,678 Reduced 8.41%	889,488 $247 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $305 Million - $422 Million	-1,016,547 Reduced 51.14%	971,166 $304 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $34.6 Million - $40.9 Million	-93,116 Reduced 4.47%	1,987,713 $816 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $32.4 Million - $38.9 Million	-96,564 Reduced 4.43%	2,080,829 $777 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $45.1 Million - $52.5 Million	-128,418 Reduced 5.57%	2,177,393 $880 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $28 Million - $33.9 Million	-98,276 Reduced 4.09%	2,305,811 $795 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $48.2 Million - $60.1 Million	-152,525 Reduced 5.97%	2,404,087 $828 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $29.9 Million - $39.1 Million	-83,298 Reduced 3.16%	2,556,612 $961 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $66.5 Million - $77.6 Million	-154,049 Reduced 5.51%	2,639,910 $1.18 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	2,793,959	2,793,959 $1.37 Billion

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.

Account